Project: lionikas_2014
1137 significantly associated models · 198 unique genes
# | chr | p0 | p1 | # assoc genes | # joint models | best TWAS P | best SNP P | cond SNP P | % var exp | joint genes |
---|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 45435209 | 47498986 | 4 | 1 | 1.2e-09 | 1.9e-08 | 5.1e-01 | 99 | Mocs2 |
2 | 2 | 110161447 | 113607123 | 4 | 1 | 3.3e-09 | 6.8e-10 | 7.8e-50 | -478 | Slc2a2 |
3 | 2 | 113624043 | 118238955 | 13 | 4 | 1.2e-09 | 7.4e-10 | 1.0e+00 | 100 | Mfn1 Ccdc39 Egfem1 NA |
4 | 4 | 17825992 | 20728817 | 4 | 1 | 8.1e-12 | 7.4e-12 | 1.0e+00 | 100 | Cacna2d1 |
5 | 5 | 16490911 | 18501601 | 2 | 1 | 1.2e-07 | 8.1e-08 | 1.0e+00 | 100 | Penk |
6 | 5 | 32364125 | 34085103 | 2 | 1 | 1.0e-07 | 4.8e-08 | 1.0e+00 | 100 | Cpne3 |
7 | 5 | 137682119 | 138752373 | 1 | 1 | 1.6e-10 | 1.6e-02 | 8.6e-11 | -625 | Stk40 |
8 | 6 | 49976875 | 52971202 | 5 | 2 | 1.3e-08 | 2.0e-09 | 4.0e-02 | 88 | Ahr Twist1 |
9 | 7 | 6527566 | 11123596 | 112 | 9 | 1.0e-08 | 6.1e-08 | 1.0e+00 | 100 | Nfic Ncln Map2k2 Zfr2 Cbarp Diras1 Apc2 Giot1 AC094643.2 |
10 | 8 | 69336832 | 77140861 | 42 | 8 | 4.2e-14 | 6.6e-14 | 1.0e+00 | 100 | Anxa2 Tmod2 Rab27a Rsl24d1 Adam10 Bnip2 Unc13c Fam81a |
11 | 8 | 102533918 | 104393934 | 4 | 1 | 1.7e-07 | 4.1e-08 | 1.0e+00 | 100 | Amotl2 |
12 | 20 | 5086090 | 6657065 | 5 | 4 | 8.3e-08 | 6.8e-08 | 1.0e+00 | 100 | Spdef Taf11 Ilrun NA |
p0: physical position of the start of the locus. p1: physical position of the end of the locus. # joint models: number of models selected by step-wise conditional analysis.
chisq ratio: Average Chi2 statistic for the selected genes in the secondary trait, divided by the average statistic for all genes in the secondary trait. # genes+: Shared significant genes at Bonferroni correction. # genes++: Shared significant genes at transcriptome-wide significance. % genes++: Number of [++] genes as a percentage of primary trait’s total joint genes. corr: Correlation of effect sizes across the [+] genes.
tissue | modality | # hits | % hits/tests | avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 14 | 0.66 | 2.8 |
Adipose | alternative TSS | 11 | 0.68 | 2.8 |
Adipose | gene expression | 57 | 0.69 | 2.9 |
Adipose | isoform ratio | 25 | 0.89 | 2.8 |
Adipose | intron excision ratio | 14 | 0.48 | 3.2 |
Adipose | mRNA stability | 22 | 0.64 | 2.8 |
BLA | alternative polyA | 8 | 0.67 | 3.1 |
BLA | alternative TSS | 7 | 0.83 | 2.9 |
BLA | gene expression | 53 | 0.87 | 2.9 |
BLA | isoform ratio | 20 | 1.14 | 3.1 |
BLA | intron excision ratio | 24 | 0.80 | 3.0 |
BLA | mRNA stability | 29 | 1.43 | 3.0 |
Brain | alternative polyA | 15 | 0.75 | 3.0 |
Brain | alternative TSS | 7 | 0.41 | 3.1 |
Brain | gene expression | 71 | 0.78 | 2.9 |
Brain | isoform ratio | 27 | 0.85 | 3.0 |
Brain | intron excision ratio | 44 | 0.81 | 3.0 |
Brain | mRNA stability | 31 | 0.71 | 2.8 |
Eye | alternative polyA | 0 | 0.00 | 2.9 |
Eye | alternative TSS | 0 | 0.00 | 2.9 |
Eye | gene expression | 7 | 0.62 | 3.0 |
Eye | isoform ratio | 5 | 1.41 | 3.3 |
Eye | intron excision ratio | 5 | 0.82 | 2.9 |
Eye | mRNA stability | 3 | 1.29 | 2.6 |
IL | alternative polyA | 9 | 1.48 | 3.3 |
IL | alternative TSS | 6 | 2.09 | 3.1 |
IL | gene expression | 28 | 0.77 | 2.9 |
IL | isoform ratio | 4 | 0.51 | 2.7 |
IL | intron excision ratio | 4 | 0.41 | 2.7 |
IL | mRNA stability | 12 | 1.08 | 3.0 |
LHb | alternative polyA | 4 | 0.70 | 2.9 |
LHb | alternative TSS | 1 | 0.29 | 2.9 |
LHb | gene expression | 22 | 0.69 | 2.9 |
LHb | isoform ratio | 6 | 0.80 | 2.7 |
LHb | intron excision ratio | 8 | 0.78 | 2.8 |
LHb | mRNA stability | 6 | 0.58 | 3.0 |
Liver | alternative polyA | 12 | 0.80 | 2.6 |
Liver | alternative TSS | 3 | 0.20 | 2.7 |
Liver | gene expression | 46 | 0.64 | 2.8 |
Liver | isoform ratio | 12 | 0.50 | 2.6 |
Liver | intron excision ratio | 27 | 0.62 | 2.9 |
Liver | mRNA stability | 15 | 0.61 | 2.8 |
NAcc | alternative polyA | 0 | 0.00 | 2.5 |
NAcc | alternative TSS | 3 | 0.88 | 2.8 |
NAcc | gene expression | 21 | 0.64 | 2.9 |
NAcc | isoform ratio | 9 | 1.21 | 3.0 |
NAcc | intron excision ratio | 2 | 0.21 | 2.6 |
NAcc | mRNA stability | 12 | 1.11 | 3.0 |
NAcc2 | alternative polyA | 2 | 0.18 | 3.0 |
NAcc2 | alternative TSS | 11 | 1.51 | 3.2 |
NAcc2 | gene expression | 53 | 0.99 | 3.0 |
NAcc2 | isoform ratio | 18 | 1.17 | 3.1 |
NAcc2 | intron excision ratio | 15 | 0.57 | 2.9 |
NAcc2 | mRNA stability | 16 | 0.90 | 3.0 |
OFC | alternative polyA | 2 | 0.34 | 2.6 |
OFC | alternative TSS | 7 | 2.19 | 3.8 |
OFC | gene expression | 32 | 0.86 | 3.0 |
OFC | isoform ratio | 4 | 0.49 | 2.7 |
OFC | intron excision ratio | 5 | 0.50 | 3.5 |
OFC | mRNA stability | 11 | 1.02 | 2.9 |
PL | alternative polyA | 4 | 0.67 | 3.0 |
PL | alternative TSS | 2 | 0.65 | 3.0 |
PL | gene expression | 33 | 0.89 | 2.9 |
PL | isoform ratio | 5 | 0.57 | 2.8 |
PL | intron excision ratio | 7 | 0.67 | 3.0 |
PL | mRNA stability | 13 | 1.13 | 3.2 |
PL2 | alternative polyA | 9 | 0.72 | 2.9 |
PL2 | alternative TSS | 7 | 0.75 | 3.1 |
PL2 | gene expression | 56 | 0.88 | 2.9 |
PL2 | isoform ratio | 12 | 0.65 | 2.9 |
PL2 | intron excision ratio | 20 | 0.63 | 3.0 |
PL2 | mRNA stability | 22 | 0.90 | 2.9 |
avg chisq: Average Chi2 (squared Z-score) across all models in this panel for this trait.